Creutzfeldt-Jakob disease (CJD) is a rare neurodegenerative human disorder
with an incidence of one case per 1 000 000 per year; Recently new diagnost
ic tests such as neuron-specific enolase (NSE), S-100, tau-protein and prot
ein 14-3-3 have been established as markers in prion diseases. NSE is eleva
ted in case of rapid nerve cell loss so quantitative measurement of NSE in
cerebrospinal fluid (CSF) might correlate with the disease progression. To
further evaluate this hypothesis we analysed longitudinal CSF samples from
-16 CJD patients. The first spinal tap was taken two weeks after the first
clinical signs of a neurodegenerative disorder. This showed an elevation of
NSE which continued during the course of the disease. Longitudinal examina
tion of neuron-specific enolase in cerebrospinal fluid therefore may be use
ful for differentiation between CJD and other dementias. (C) 1999 Published
by Elsevier Science Ireland Ltd. All rights reserved.